Lobby organisation
Avicenna Alliance
NGO or non-profit · Health & pharma · HQ: Belgium · Transparency Register entry
As of 8 October 2026, Avicenna Alliance appears in 3 declared MEP meetings (3 different MEPs), most often with European People's Party.
In their own words
“The Avicenna Alliance is a global non-profit organization bringing together health care stakeholders with the goal of making in silico medicine standard practice in health care through a collaborative ecosystem of patients, clinicians, academics, industries, policy makers, regulators & payers.”
Read the rest of the statementShow less of the statement
“The Avicenna Alliance seeks to significantly accelerate medical innovation and its practical implementation, to ensure safe, affordable and cost-effective healthcare through the large-scale adoption of in silico medicine and by making in silico medicine a standard practice in healthcare. The Alliance’s objectives include: • Ensure a forward-looking policy framework to facilitate the large-scale development and acceptance of in silico medicine • Work on developing international guidelines and standards for in silico methods such as a Good Simulation Practice document • Bridge the gap between basic research and the commercialisation of products by exploring areas of mutual cooperation and benefits […]”
Stated goals from the organisation's own Transparency Register filing - the text on file breaks off mid-sentence where marked […].
Who they meet, and when
Which groups they meet
Share of this organisation's 3 declared meetings, by the meeting MEP's political group.
Meetings by year
Declared meetings per calendar year, 2019–2025. Bar length is relative to its busiest year (1 in 2019).
Group is each MEP's current political group, not necessarily the one they sat with at the time. Shares are rounded to whole percent.
The MEPs they meet most
The 3 most recent declared meetings
| Date | MEP | Subject |
|---|---|---|
| 17 Feb 2025 | András Tivadar Kulja | Invitro diagnostics, VDR |
| 23 Oct 2023 | Laura Ballarín Cereza | Pharmaceutical Package (Regulation) |
| 18 Sep 2019 | Tilly Metz | In silico medicine, IT-based alternatives to animal testing for drugs |
Meeting an MEP is a normal part of democratic life; the record is shown so anyone can see it.